My HPRA: Register

OCTANATE

250 International Unit Pdr+Solv for Soln for Inj

Octapharma LimitedPA0521/012/001

SPC: DATE OF REVISION OF THE TEXT

16 May 2015 - 25 Jun 2016	25 Jun 2016 - Present
December 2012	June 2016

« Back

Follow medicine

Print

Latest Changes to Medicine Info & SPC

25 Jun 2016
SPC: DATE OF REVISION OF THE TEXT
25 Jun 2016
SPC: DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION
25 Jun 2016
SPC: MARKETING AUTHORISATION NUMBER
25 Jun 2016
SPC: Special precautions for disposal and other handling
25 Jun 2016
SPC: Nature and contents of container
25 Jun 2016
SPC: Shelf life
25 Jun 2016
SPC: Preclinical safety data
25 Jun 2016
SPC: Pharmacokinetic properties
25 Jun 2016
SPC: Pharmacodynamic properties
25 Jun 2016
SPC: Overdose
25 Jun 2016
SPC: Undesirable effects
25 Jun 2016
SPC: Effects on ability to drive and use machines
25 Jun 2016
SPC: Fertility, pregnancy and lactation
25 Jun 2016
SPC: Interaction with other medicinal products and other forms of interaction
25 Jun 2016
SPC: Special warnings and precautions for use
25 Jun 2016
SPC: Contraindications
25 Jun 2016
SPC: Posology and method of administration
25 Jun 2016
SPC: Therapeutic Indications
25 Jun 2016
SPC: QUALITATIVE AND QUANTITATIVE COMPOSITION
11 Jun 2016
Trade Name
07 Aug 2015
Promotion Status
07 Aug 2015
Supply Status
23 Jul 2015
Promotion Status
23 Jul 2015
Supply Status

Please note changes to the medicine information and summary of product characteristics are only available from the 19/05/2015 onwards. Changes made before this date aren't available online.

Important information regarding cookies and the HPRA

By using this website, you consent to the use of cookies in accordance with the HPRA Cookie Policy.
For more information on cookies, see our cookie policy.

Click here to accept the cookie policy and hide this message